Our understanding of nonalcoholic fatty liver disease pathophysiology continues to advance
rapidly. Accordingly, the field has moved from describing the clinical phenotype through the …

Background Metabolic dysfunction-associated steatohepatitis (MASH) is an inflammatory
subtype of metabolic dysfunction-associated steatotic liver disease (MASLD) has recently …

Background. Fatty liver index (FLI) is a non-invasive tool used to stratify the risk of non-
alcoholic fatty liver disease (NAFLD) in population studies; whether it can be used to …

In the United States, chronic viral hepatitis B and C (CHB and CHC), nonalcoholic fatty liver
disease (NAFLD), and alcohol‐related liver disease (ALD) are the main causes of liver …

Common genetic variants in glucokinase regulator (GCKR), which encodes GKRP, a
regulator of hepatic glucokinase (GCK), influence multiple metabolic traits in genome-wide …

Purpose The aim of this paper is to summarize the allocation challenges facing the field of
liver transplantation while providing examples of the expansion of indications for the …

Background: There are limited data on outcomes of older patients with chronic diseases.
Skeletal muscle loss of aging (primary sarcopenia) has been extensively studied but the …

METHODS: Four databases were searched until December 2020 (CRD42021224766).
Original articles reporting data on the performance of FIB-4 and NFS, interpreted according …

Background. Hepatocellular carcinoma (HCC) is most commonly considered as a
complication of cirrhosis. However, an increasing number of HCC in subjects with non …

Background. The optimal cardiovascular (CV) risk stratification in liver transplant (LT)
candidates remains unclear. The aim of this study was to evaluate concordance of findings …